Literature DB >> 10724

Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts.

S Wood, B G MacDougall.   

Abstract

The residual hexosaminidase isoenzymes in juvenile Sandhoff and infantile Sandhoff disease fibroblasts, have been determined by starch gel electrophoresis and column isoelectric focusing. Hex A and hex S are the major residual isozymes in fibroblasts from the juvenile patient, while hex B is barely detectable. Only hex S could be detected in fibroblasts from infantile Sandhoff patients. These results suggest that the defects in juvenile and infantile Sandhoff disease may be different allelic modifications of the beta subunit common to hex A and hex B.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10724      PMCID: PMC1685102     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes.

Authors:  E Beutler; W Kuhl
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).

Authors:  J U Ikonne; M C Rattazzi; R J Desnick
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

4.  Hexosaminidase-A and hexosaminidase-B: studies in Tay-Sachs' and Sandhoff's disease.

Authors:  S K Srivastava; E Beutler
Journal:  Nature       Date:  1973-02-16       Impact factor: 49.962

5.  Five gangliosidoses.

Authors:  J S O'Brien
Journal:  Lancet       Date:  1969-10-11       Impact factor: 79.321

6.  On the molecular basis of Sandhoff's disease.

Authors:  H H Ropers; U Schwantes
Journal:  Humangenetik       Date:  1973

7.  Sandhoff's disease (GM 2 gangliosidosis type 2): clinical, chemical, and enzyme studies in five patients.

Authors:  S Okada; M McCrea; J S O'Brien
Journal:  Pediatr Res       Date:  1972-07       Impact factor: 3.756

8.  Enzyme alterations and lipid storage in three variants of Tay-Sachs disease.

Authors:  K Sandhoff; K Harzer; W Wässle; H Jatzkewitz
Journal:  J Neurochem       Date:  1971-12       Impact factor: 5.372

9.  Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).

Authors:  E Beutler; W Kuhl; D Comings
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

10.  Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes.

Authors:  F Gilbert; R Kucherlapati; R P Creagan; M J Murnane; G J Darlington; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

View more
  10 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

Review 3.  Progress in investigations of sphingolipidoses.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

4.  Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.

Authors:  R M Cantor; J S Lim; C Roy; M M Kaback
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

5.  An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds.

Authors:  B McInnes; M Potier; N Wakamatsu; S B Melancon; M H Klavins; S Tsuji; D J Mahuran
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Carrier detection in Sandhoff disease.

Authors:  J A Lowden; E J Ives; D L Keene; A L Burton; M A Skomorowski; F Howard
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

7.  Juvenile Sandhoff Disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion.

Authors:  S Wood
Journal:  Hum Genet       Date:  1978-04-24       Impact factor: 4.132

8.  Purification and properties of the hexosaminidase A-activating protein from human liver.

Authors:  P Hechtman; D LeBlanc
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

9.  Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.

Authors:  W G Johnson; C S Cohen; A F Miranda; S P Waran; A M Chutorian
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

10.  Sandhoff disease mimicking adult-onset bulbospinal neuronopathy.

Authors:  P K Thomas; E Young; R H King
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.